Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness

被引:33
作者
Orgel, Kelly [1 ,2 ]
Burk, Caitlin [1 ,2 ]
Smeekens, Johanna [1 ,2 ]
Suber, Jada [1 ,2 ]
Hardy, Lakeya [1 ,2 ]
Guo, Rishu [1 ,2 ]
Burks, A. Wesley [1 ,2 ]
Kulis, Michael [1 ,2 ]
机构
[1] UNC Sch Med, Dept Pediat, Chapel Hill, NC USA
[2] UNC Food Allergy Initiat, Chapel Hill, NC USA
关键词
basophil activation; food allergy; IgG; immunoglobulin; immunotherapy; peanut allergy; DESENSITIZATION; ALLERGY; IGE; OIT;
D O I
10.1111/cea.13305
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Oral and sublingual immunotherapies for peanut allergy have demonstrated efficacy in small clinical trials; however, mechanisms and biomarkers correlating with clinical outcomes remain elusive. Previous studies have demonstrated a role for IgG in post-OIT plasma in the suppression of IgE-mediated mast cell reactions. Objective: The aim of this study was to characterize the role that peanut oral and sublingual immunotherapy-induced plasma factors play in the inhibition of ex vivo basophil activation and whether inhibitory activity is associated with clinical outcomes. Methods: Plasma samples from subjects on placebo, peanut oral immunotherapy (OIT) or peanut sublingual immunotherapy (SLIT), and IgG-depleted plasma or the IgG fraction were incubated with sensitized basophils, and the inhibition of basophil activation following stimulation with peanut extract was measured. Basophil inhibition results were compared between the two routes of immunotherapy, time on treatment and clinical outcomes. Results: Plasma from subjects after 12 months of active peanut OIT, but not placebo, inhibits basophil activation ex vivo. Depletion of IgG abrogated the blocking effect of OIT plasma, while the IgG fraction substantially blocked basophil activation. Basophils are inhibited to a similar extent by undiluted OIT and SLIT plasma; however, diluted OIT plasma from the time of desensitization challenge inhibited basophils more than diluted SLIT plasma from time of desensitization challenge. Plasma from subjects who experienced sustained unresponsiveness following OIT inhibited basophils to a greater extent than plasma from subjects who were desensitized, but this was not true for SLIT. Conclusions and Clinical Relevance: Peanut immunotherapy induces IgG-dependent functional changes in plasma that are associated with OIT but not SLIT clinical outcomes. Understanding the mechanisms of peanut OIT and SLIT may help derive informative biomarkers.
引用
收藏
页码:461 / 470
页数:10
相关论文
共 28 条
[1]   Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial [J].
Anagnostou, Katherine ;
Islam, Sabita ;
King, Yvonne ;
Foley, Loraine ;
Pasea, Laura ;
Bond, Simon ;
Palmer, Chris ;
Deighton, John ;
Ewan, Pamela ;
Clark, Andrew .
LANCET, 2014, 383 (9925) :1297-1304
[2]   Mast cell desensitization inhibits calcium flux and aberrantly remodels actin [J].
Ang, W. X. Gladys ;
Church, Alison M. ;
Kulis, Mike ;
Choi, Hae Woong ;
Burks, A. Wesley ;
Abraham, Soman N. .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (11) :4103-4118
[3]   Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects [J].
Arzt, L. ;
Bokanovic, D. ;
Schrautzer, C. ;
Laipold, K. ;
Moebs, C. ;
Pfuetzner, W. ;
Herzog, S. A. ;
Vollmann, J. ;
Reider, N. ;
Bohle, B. ;
Aberer, W. ;
Sturm, G. J. .
ALLERGY, 2018, 73 (06) :1223-1231
[4]   The rise of food allergy: Environmental factors and emerging treatments [J].
Benede, Sara ;
Blazquez, Ana Belen ;
Chiang, David ;
Tordesillas, Leticia ;
Berin, M. Cecilia .
EBIOMEDICINE, 2016, 7 :27-34
[5]   Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical Trials [J].
Berglund, Jelena P. ;
Szczepanski, Nicole ;
Penumarti, Anusha ;
Beavers, Ayeshia ;
Kesselring, Janelle ;
Orgel, Kelly ;
Burnett, Bruce ;
Burks, A. Wesley ;
Kulis, Michael .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (04) :1098-1104
[6]   Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial [J].
Burks, A. Wesley ;
Wood, Robert A. ;
Jones, Stacie M. ;
Sicherer, Scott H. ;
Fleischer, David M. ;
Scurlock, Amy M. ;
Vickery, Brian P. ;
Liu, Andrew H. ;
Henning, Alice K. ;
Lindblad, Robert ;
Dawson, Peter ;
Plaut, Marshall ;
Sampson, Hugh A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (05) :1240-U648
[7]   Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity [J].
Burton, Oliver T. ;
Logsdon, Stephanie L. ;
Zhou, Joseph S. ;
Medina-Tamayo, Jaciel ;
Abdel-Gadir, Azza ;
Noval Rivas, Magali ;
Koleoglou, Kyle J. ;
Chatila, Talal A. ;
Schneider, Lynda C. ;
Rachid, Rima ;
Umetsu, Dale T. ;
Oettgen, Hans C. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (06) :1310-+
[8]  
Chin SJ, 2013, J ALLERGY CLIN IMMUN, V132, P476
[9]   The natural progression of peanut allergy: Resolution and the possibility of recurrence [J].
Fleischer, DM ;
Conover-Walker, MK ;
Christie, L ;
Burks, AW ;
Wood, RA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (01) :183-189
[10]   Potential Mechanisms for IgG4 Inhibition of Immediate Hypersensitivity Reactions [J].
James, Louisa K. ;
Till, Stephen J. .
CURRENT ALLERGY AND ASTHMA REPORTS, 2016, 16 (03) :1-7